Company / Assets per Share
Rein Therapeutics, Inc. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.12
FY2025
5-year range
$1.11 / $23.34
FY2021-FY2025
Trend
-91.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $23.34 to $1.12 over the past 2 years.
Based on SEC 10-K filings.
1.12 in FY2025 with a 5-year CAGR of +13.7%.
Declined from $23.34 to $1.12 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -38.8%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 91.2% year-over-year.
- Peak assets per share was recorded in FY2017.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.12 | -91.2% |
| FY2024 | $12.73 | -45.5% |
| FY2023 | $23.34 | +380.4% |
| FY2022 | $4.86 | +339.1% |
| FY2021 | $1.11 | +88.4% |
| FY2020 | $0.59 | -67.3% |
| FY2019 | $1.79 | -12.8% |
| FY2018 | $2.06 | -98.3% |
| FY2017 | $121.85 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026